NCT02881294View on ClinicalTrials.gov

A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Cognitive Disorders
Interventions
DRUG

SUVN-G3031

Trial Locations (1)

66211

Quintiles, Overland Park

All Listed Sponsors
lead

Suven Life Sciences Limited

INDUSTRY

NCT02881294 - A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects | Biotech Hunter | Biotech Hunter